Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SSR504734

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Pharmacological stimulation of N‐methyl‐D‐aspartate receptors (NMDAr) could enhance the outcome of cue‐exposure therapy for… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Translational control depends on phosphorylation of eIF2α by PKR-like ER kinase (PERK). To examine the role of PERK in cognitive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Conditioned stress-induced freezing has been used as an indicator of anxiety in rodents to evaluate the anxiolytic effects of… Expand
Is this relevant?
2009
2009
The specific glycine transporter 1 (GlyT1) inhibitor, SSR504734, is highly effective in enhancing N-methyl-D-aspartate receptor… Expand
Is this relevant?
2008
2008
RationaleInhibition of the glycine transporter 1 (GlyT1) activity increases extra-cellular glycine availability in the CNS. At… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
RationaleSSR103800 and SSR504734 are novel glycine transport 1 (GlyT1) inhibitors with therapeutic potential for the treatment of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
RationaleIncreasing experimental evidence suggests that impaired N-methyl-d-aspartic acid (NMDA) receptor (NMDAr) function could… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
In the forebrain, synaptic glycine concentrations are regulated through the glycine transporter GlyT1. Because glycine is a… Expand
Is this relevant?
2006
2006
2-Chloro-N-S-phenyl 2S-piperidin-2-yl methyl]-3-trifluoromethyl benzamide, monohydrochloride (SSR504734) is a potent and… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Noncompetitive N-methyl-D-aspartate (NMDA) blockers induce schizophrenic-like symptoms in humans, presumably by impairing… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?